No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Multicenter Study
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Colitis, Ulcerative / drug therapy*
-
Double-Blind Method
-
Drug Resistance*
-
Female
-
Heptanoates / therapeutic use*
-
Humans
-
Male
-
Mesalamine / therapeutic use*
-
Middle Aged
-
Placebos
-
Receptors, Prostaglandin E / agonists*
-
Receptors, Prostaglandin E, EP4 Subtype
-
Treatment Outcome
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Heptanoates
-
ONO4819
-
PTGER4 protein, human
-
Placebos
-
Receptors, Prostaglandin E
-
Receptors, Prostaglandin E, EP4 Subtype
-
Mesalamine